Publicaciones en colaboración con investigadores/as de Universidade de Lisboa (21)

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. miR-21-5p promotes NASH-related hepatocarcinogenesis

    Liver International, Vol. 43, Núm. 10, pp. 2256-2274

2022

  1. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models

    Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190

2021

  1. Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)

    British Journal of Cancer

  2. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease

    Gut, Vol. 70, Núm. 12, pp. 2359-2372

2020

  1. Current and novel therapeutic opportunities for systemic therapy in biliary cancer

    British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059

  2. Diet-dependent gut microbiota impacts on adult neurogenesis through mitochondrial stress modulation

    Brain Communications, Vol. 2, Núm. 2

  3. Extracellular vesicles in non-alcoholic fatty liver disease: Key players in disease pathogenesis and promising biomarker tools

    NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring (Springer International Publishing), pp. 157-180

2019

  1. Diagnostic and prognostic biomarkers in cholangiocarcinoma

    Liver International, Vol. 39, Núm. S1, pp. 108-122

  2. Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis

    Journal of Molecular Medicine, Vol. 97, Núm. 8, pp. 1113-1126

2018

  1. MiRNA-21 ablation protects against liver injury and necroptosis in cholestasis

    Cell Death and Differentiation, Vol. 25, Núm. 5, pp. 857-872

  2. Modulation of liver steatosis by miR-21/PPARα

    Cell Death Discovery

2017

  1. MiR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice

    Cell Death and Disease, Vol. 8, Núm. 4

2016

  1. Activation of necroptosis in human and experimental cholestasis

    Cell Death and Disease, Vol. 7, Núm. 9

  2. Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma

    Journal of Clinical Medicine, Vol. 5, Núm. 3

2015

  1. Inhibition of NF-κ B by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis

    Scientific Reports, Vol. 5

  2. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis

    Clinical Science, Vol. 129, Núm. 8, pp. 721-739

2014

  1. c-jun N-terminal kinase 1/c-jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver

    Molecular and Cellular Biology, Vol. 34, Núm. 6, pp. 1100-1120

2013

  1. Delivering the promise of miRNA cancer therapeutics

    Drug Discovery Today, Vol. 18, Núm. 5-6, pp. 282-289

  2. Efficient recovery of proteins from multiple source samples after trizol® or trizol®LS RNA extraction and long-term storage

    BMC Genomics, Vol. 14, Núm. 1